- COVID-19
- Vaccine Recommendations
What is the difference between an “additional primary dose” of COVID-19 vaccine recommended for an immunocompromised person and a “booster dose”?
CDC defines an “additional primary dose” as a subsequent dose of vaccine administered to people who are less likely to develop a protective immune response after initial vaccination because of moderate or severe immunocompromise. All previously unvaccinated people with moderate or severe immunocompromise are recommended to receive an initial 3-dose primary COVID-19 series.
CDC defines a “booster dose” as a subsequent dose of vaccine administered to enhance or restore protection which might have declined over time after primary series vaccination.